COP1 and Miyoshi myopathy: Then, qPCR and WB were recruited to validate the efficiency of shRNA, which demonstrated the significant decrease of RFWD2 at mRNA and protein levels in RFWD2-shRNA transfected MM cells (KD) compared to the WT cells (Figure 3B up and down).